Pfanstiehl Solutions for Complex Bispecific or Trispecific Antibody Formulations

By Pfanstiehl

Stabilising bispecific or trispecific monoclonal antibodies (mAbs) presents several challenges due to their complex structures and the increased likelihood of instability compared to traditional monoclonal antibodies.

These include issues of structural complexity, chemical instability, manufacturing challenges, aggregation, and physical instability.

To read more, please download this free white paper.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.